SE14 Antibody

Shipped with Ice Packs
In Stock

Description

IC14 (Atibuclimab): Anti-CD14 Monoclonal Antibody

IC14 is a chimeric monoclonal antibody targeting CD14, a co-receptor for lipopolysaccharide (LPS) signaling in innate immunity.

Key Features:

PropertyDetailsSource(s)
TargetMembrane-bound CD14 on monocytes/macrophages
MechanismBlocks LPS-induced inflammatory responses by saturating CD14 receptors
Clinical Applications- Sepsis: Reduces systemic inflammation and organ dysfunction (Phase 1/2 trials)
- ALS: Safe in expanded-access protocols; modulates T-regulatory cells
DosingAchieves >80% receptor occupancy (RO) at 4 mg/kg; adjusted based on RO monitoring

Recent Findings:

  • In severe COVID-19 trials, IC14 showed a trend toward reduced mortality (adjusted HR: 0.33 in presepsin-high patients) but did not meet primary efficacy endpoints .

  • Phase 1 sepsis trials demonstrated safety, with transient cytokine modulation and no increased infection risk .

AM14: Prefusion-Specific RSV Antibody

AM14 is a human monoclonal antibody targeting the prefusion conformation of the respiratory syncytial virus (RSV) fusion (F) glycoprotein.

Comparison of IC14 and AM14

FeatureIC14 (Anti-CD14)AM14 (Anti-RSV F)
TargetHuman CD14 receptorRSV fusion glycoprotein (prefusion form)
Therapeutic AreaSepsis, ALS, COVID-19Infectious diseases (RSV prophylaxis)
Development StagePhase 2 trials (COVID-19/sepsis)Preclinical characterization
Key MechanismCD14 receptor occupancy; immunomodulationViral neutralization via trimer disruption
Clinical SafetyWell-tolerated; no increased infection riskNot yet assessed in humans

Research Gaps and Limitations

  • SE14 Antibody: No peer-reviewed data or clinical references exist for an antibody named "SE14" in biological or medical literature.

  • IC14 and AM14: While structurally and functionally distinct, both demonstrate the importance of antibody specificity in modulating immune responses (IC14) or viral entry (AM14).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SE14 antibody; Os03g0151300 antibody; LOC_Os03g05690 antibody; Lysine-specific demethylase SE14 antibody; EC 1.14.11.- antibody; Protein PHOTOPERIOD SENSITIVITY 14 antibody
Target Names
SE14
Uniprot No.

Target Background

Function
This antibody targets a histone demethylase enzyme that removes methyl groups from lysine 4 of histone H3 (H3K4me). This enzyme plays a crucial role in regulating flowering time in plants. Under long day conditions, it suppresses floral transition by demethylating H3K4me3 at the promoter region of the flower-promoting signal HD3B/RFT1.
Database Links
Subcellular Location
Nucleus.

Q&A

What is SE14 Antibody and what is its target?

SE14 Antibody is a polyclonal antibody that specifically targets the SE14 protein found in Oryza sativa subsp. japonica (Rice). The antibody is developed using recombinant Oryza sativa subsp. japonica SE14 protein as the immunogen. As a polyclonal antibody, it recognizes multiple epitopes on the target protein, which can provide robust detection capabilities in various experimental applications. This antibody is intended exclusively for research applications and should not be used in diagnostic or therapeutic procedures .

What are the optimal storage conditions for SE14 Antibody?

Upon receipt, SE14 Antibody should be stored at -20°C or -80°C to maintain its activity and specificity. It is crucial to avoid repeated freeze-thaw cycles as these can compromise antibody function through protein denaturation and aggregation. The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. This formulation helps maintain stability during storage periods. When working with the antibody, aliquoting into smaller volumes before freezing is recommended to minimize the need for repeated freezing and thawing .

What applications has SE14 Antibody been verified for?

SE14 Antibody has been tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications. These applications allow researchers to detect and quantify SE14 protein in various sample types. The antibody undergoes purification by antigen affinity methods, which enhances its specificity for the target protein. When designing experiments, researchers should consider that this antibody has been specifically tested with rice samples and may require additional validation for other experimental systems .

How does antibody affinity purification impact experimental outcomes with SE14 Antibody?

SE14 Antibody undergoes antigen affinity purification, which significantly influences its performance in experimental settings. This purification method isolates antibodies that specifically bind to the target antigen (SE14 protein), resulting in reduced background and increased signal-to-noise ratio in applications like ELISA and Western blotting. The purification process involves immobilizing the target antigen on a solid support and washing away non-specific antibodies, leaving only those with high affinity for the SE14 protein.

Researchers should note that while affinity purification enhances specificity, it may reduce the diversity of epitopes recognized compared to crude antiserum. When troubleshooting unexpected results, consider that extremely high affinity can sometimes lead to difficulties in eluting the antibody from the target in certain applications like immunoprecipitation. Additionally, the affinity purification process may selectively enrich for antibodies recognizing dominant epitopes, potentially limiting detection of conformational variants of the target protein .

What experimental controls are essential when using SE14 Antibody in plant research?

When designing experiments with SE14 Antibody in plant research, several controls are critical for result validation:

  • Positive Control: Samples known to express SE14 protein, preferably from Oryza sativa subsp. japonica varieties with confirmed SE14 expression.

  • Negative Control: Samples from plant species or tissues that do not express SE14 protein, or SE14 knockout/knockdown rice plants if available.

  • Isotype Control: Use of irrelevant rabbit polyclonal IgG antibodies at matching concentrations to evaluate non-specific binding.

  • Loading Controls: For Western blotting, include detection of housekeeping proteins (e.g., actin or tubulin) to normalize protein loading across samples.

  • Blocking Peptide Control: If available, pre-incubation of the antibody with excess recombinant SE14 protein should abolish specific signals in your application.

These controls help distinguish between specific and non-specific signals, ensuring experimental rigor and reproducibility. Particularly when studying protein expression across different rice varieties or under various environmental conditions, these controls become essential for meaningful comparative analyses .

How can epitope availability affect SE14 Antibody performance in different applications?

Several factors can affect epitope availability:

FactorImpact on Epitope AvailabilityMitigation Strategy
Fixation methodsChemical fixatives can mask epitopesOptimize fixation protocols; consider antigen retrieval
Buffer compositionpH and salt concentration affect protein foldingTest multiple buffer systems
Sample preparationMechanical disruption can expose hidden epitopesStandardize sample preparation methods
Post-translational modificationsCan block antibody binding sitesConsider enrichment methods before immunodetection
Protein-protein interactionsMay obscure target epitopesInclude detergents or denaturants at low concentrations

Researchers should systematically optimize conditions to maximize epitope accessibility while maintaining the integrity of their experimental system. For complex samples, pre-treatment steps such as heat-induced epitope retrieval might be necessary to achieve optimal detection sensitivity .

What is the recommended protocol for using SE14 Antibody in Western blotting?

For optimal Western blotting results with SE14 Antibody, follow this methodological approach:

  • Sample Preparation: Extract total protein from rice tissues using an appropriate extraction buffer (e.g., containing 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, and protease inhibitors). Quantify protein concentration using Bradford or BCA assay.

  • Gel Electrophoresis: Separate 20-50μg of protein per lane on 7.5-12% SDS-PAGE gel (select percentage based on expected molecular weight of SE14 protein).

  • Transfer: Transfer proteins to PVDF or nitrocellulose membrane using standard transfer conditions (100V for 1 hour or 30V overnight).

  • Blocking: Block the membrane with 5% non-fat dry milk or 3-5% BSA in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.

  • Primary Antibody Incubation: Dilute SE14 Antibody 1:500 to 1:2000 in blocking buffer. Incubate overnight at 4°C with gentle rocking.

  • Washing: Wash membrane 3-5 times with TBST, 5 minutes per wash.

  • Secondary Antibody: Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000 to 1:10000) for 1 hour at room temperature.

  • Detection: After washing steps, develop using ECL substrate and image according to standard laboratory protocols.

  • Expected Results: Compare band position to the predicted molecular weight of SE14 protein. Verify specificity with appropriate controls.

This protocol should be optimized based on laboratory-specific conditions and equipment. The primary antibody dilution may require adjustment depending on the expression level of the target protein and the sensitivity of your detection system .

How should researchers troubleshoot weak or absent signals when using SE14 Antibody?

When encountering weak or absent signals with SE14 Antibody, systematic troubleshooting is essential. Consider these methodological approaches:

  • Antibody Concentration: Increase antibody concentration by using a lower dilution factor (e.g., 1:500 instead of 1:2000). This can enhance signal strength but may also increase background.

  • Incubation Conditions: Extend primary antibody incubation time (up to 48 hours at 4°C) or try room temperature incubation (1-2 hours) to improve antibody-antigen binding kinetics.

  • Protein Loading: Increase the amount of total protein loaded per lane (up to 100μg) to ensure sufficient target protein is present.

  • Detection System: Switch to a more sensitive detection system, such as enhanced chemiluminescence (ECL) Plus or femto-sensitivity substrates.

  • Sample Preparation: Ensure sample preparation methods preserve protein integrity. Consider adding additional protease inhibitors or reducing extraction time.

  • Membrane Type: PVDF membranes generally provide better protein retention than nitrocellulose and may improve results with low-abundance proteins.

  • Blocking Reagent: Test alternative blocking agents (e.g., switch from milk to BSA) as some blocking reagents can mask certain epitopes.

  • Transfer Efficiency: Verify transfer efficiency using reversible protein stains like Ponceau S before immunodetection.

  • Antibody Integrity: Check antibody storage conditions; degraded antibodies will show reduced binding capacity.

Document all optimization steps systematically to establish the most reproducible protocol for your specific experimental system .

What are the optimal protocols for using SE14 Antibody in ELISA applications?

For effective use of SE14 Antibody in ELISA applications, follow this detailed protocol:

  • Coating: Coat ELISA plate wells with antigen (purified SE14 protein or rice tissue extract) at 1-10μg/ml in carbonate buffer (pH 9.6) overnight at 4°C.

  • Blocking: Block non-specific binding sites with 3% BSA or 5% non-fat dry milk in PBS for 1-2 hours at room temperature.

  • Primary Antibody: Dilute SE14 Antibody in blocking buffer at ratios from 1:1000 to 1:5000 (optimize for your specific application). Incubate for 2 hours at room temperature or overnight at 4°C.

  • Washing: Wash 4-5 times with PBST (PBS + 0.05% Tween-20) to remove unbound antibody.

  • Secondary Antibody: Add HRP-conjugated anti-rabbit IgG (typically 1:5000 to 1:10000) and incubate for 1 hour at room temperature.

  • Development: After washing, add TMB substrate and monitor color development. Stop the reaction with 2N H₂SO₄ when appropriate signal intensity is achieved.

  • Detection: Measure absorbance at 450nm using a plate reader.

For indirect ELISA, the antigen is immobilized directly on the plate. For sandwich ELISA, a capture antibody specific to SE14 protein must first be immobilized before adding the sample containing the antigen. The detection limit of this method typically ranges from 10-100pg/ml depending on optimization parameters and antibody affinity .

How should SE14 Antibody be integrated into studies investigating protein-protein interactions in rice?

When designing studies to investigate protein-protein interactions involving SE14 protein in rice, several methodological approaches can be employed:

  • Co-Immunoprecipitation (Co-IP): SE14 Antibody can be used to pull down SE14 protein along with its interacting partners. The protocol should include:

    • Pre-clearing lysates with protein A/G beads

    • Incubating cleared lysate with SE14 Antibody (typically 2-5μg per 500μg protein)

    • Capturing antibody-protein complexes with protein A/G beads

    • Washing under conditions that maintain protein-protein interactions

    • Eluting and analyzing by mass spectrometry or Western blotting

  • Proximity Ligation Assay (PLA): This technique can detect protein interactions in situ by using SE14 Antibody in combination with antibodies against potential interacting partners.

  • Bimolecular Fluorescence Complementation (BiFC): While not directly using the antibody, BiFC results can be validated using SE14 Antibody in parallel experiments.

  • Pull-down Validation: For interactions identified through yeast two-hybrid or other screening methods, SE14 Antibody can be used to validate the presence of interacting proteins in pull-down fractions.

Critical controls include using non-specific rabbit IgG for background determination, input samples to verify protein expression levels, and when possible, samples from SE14 knockout/knockdown plants as negative controls. Consider that the polyclonal nature of the antibody provides an advantage in recognizing multiple epitopes, potentially preserving detection even if some interaction surfaces are occupied .

What considerations are important when using SE14 Antibody for comparative analysis across different rice varieties?

When utilizing SE14 Antibody for comparative analyses across different rice varieties, researchers must address several critical methodological considerations:

  • Sequence Homology Assessment: Before experimentation, analyze SE14 protein sequence conservation across target rice varieties. Even minor amino acid variations can affect epitope recognition and antibody binding affinity. Perform sequence alignments to identify potential regions of variability.

  • Sensitivity Calibration: Establish a standard curve using purified recombinant SE14 protein to ensure quantitative comparisons are accurate across varieties. This calibration should be performed for each experimental batch.

  • Sample Normalization: Standardize protein extraction methods across all varieties to ensure comparable protein yields and quality. Equal protein loading should be verified using:

    • Total protein stains (Ponceau S, SYPRO Ruby)

    • Housekeeping protein detection (actin, tubulin)

    • Consideration of differential expression of reference proteins across varieties

  • Cross-Reactivity Testing: Pre-test the antibody against proteins from each variety to identify any differential binding characteristics.

  • Technical Replication Strategy: Include multiple technical replicates (minimum three) for each biological sample to account for antibody binding variability.

  • Data Normalization Approach: Consider using relative quantification rather than absolute values when comparing signal intensities across varieties. Report fold-changes relative to a reference variety rather than raw intensity values.

These methodological precautions help mitigate variability introduced by genetic differences and ensure that observed differences in signal intensity genuinely reflect differences in SE14 protein expression rather than antibody affinity variations .

How does the polyclonal nature of SE14 Antibody impact experimental design compared to monoclonal alternatives?

The polyclonal nature of SE14 Antibody has significant implications for experimental design compared to potential monoclonal alternatives:

CharacteristicImpact on Experimental DesignMethodological Considerations
Multiple epitope recognitionIncreased robustness against minor protein modifications or degradationLess sensitive to epitope masking; useful for detecting proteins in different conformational states
Batch-to-batch variabilityMay require additional validation between antibody lotsInclude positive controls with each new lot; consider purchasing larger quantities of a single lot for long-term studies
Higher sensitivityGenerally provides stronger signals due to multiple binding sites per target moleculeMay allow for higher dilution factors and conservation of antibody; can detect lower abundance proteins
Potential for cross-reactivityIncreased chance of non-specific bindingRequire more rigorous negative controls; pre-adsorption against related proteins may be necessary
Superior for precipitation applicationsMultiple binding epitopes enhance precipitation efficiencyParticularly valuable for immunoprecipitation of low-abundance proteins or complexes

When designing experiments, researchers should leverage the polyclonal advantages for applications requiring high sensitivity (like detecting low expression levels of SE14 in certain tissues) while implementing appropriate controls to address potential cross-reactivity. For studies requiring absolute epitope specificity or where reproducibility across many batches is critical, development of monoclonal alternatives might be considered as a long-term strategy .

How should researchers quantitatively analyze Western blot data generated using SE14 Antibody?

Quantitative analysis of Western blot data generated with SE14 Antibody requires rigorous methodological approaches to ensure accuracy and reproducibility:

  • Image Acquisition: Capture images using a digital imaging system with a linear dynamic range (e.g., CCD camera-based systems). Avoid film-based methods for quantitative work due to non-linear response characteristics.

  • Exposure Optimization: Capture multiple exposures to ensure signal is within the linear range of detection. Overexposed bands cannot be accurately quantified.

  • Analysis Software Selection: Use specialized software (ImageJ, Image Studio, etc.) that can perform densitometry while accounting for background.

  • Background Subtraction Method: Apply consistent background subtraction methods across all samples:

    • Rolling ball algorithm for uneven backgrounds

    • Lane-specific background subtraction for lane-to-lane variations

  • Normalization Strategy:

    • Normalize SE14 signal to loading controls (housekeeping proteins)

    • Consider total protein normalization using stain-free gels or Ponceau S staining

    • Account for potential variability in housekeeping protein expression across experimental conditions

  • Technical Replication: Analyze at least three independent blots for statistical validity.

  • Statistical Analysis: Apply appropriate statistical tests based on experimental design:

    • t-test for two-group comparisons

    • ANOVA for multiple group comparisons

    • Non-parametric alternatives if normality assumptions are violated

  • Data Presentation: Report relative rather than absolute values, presenting results as fold-change compared to control conditions.

This methodological framework ensures that quantitative comparisons of SE14 protein levels are scientifically sound and reproducible across different experimental settings .

What validation approaches should be employed to confirm the specificity of SE14 Antibody in new experimental systems?

When adapting SE14 Antibody to new experimental systems, comprehensive validation is essential to ensure specificity. Researchers should implement these methodological approaches:

  • Peptide Competition Assay: Pre-incubate SE14 Antibody with excess purified recombinant SE14 protein (10-100 fold molar excess) before application in the experimental system. Specific signals should be significantly reduced or eliminated.

  • Knockout/Knockdown Validation: If available, utilize SE14 knockout or knockdown plant materials as negative controls. The absence or reduction of signal in these samples confirms antibody specificity.

  • Heterologous Expression: Express tagged SE14 protein in a heterologous system (e.g., E. coli, yeast) and verify detection by both the SE14 Antibody and an antibody against the tag.

  • Mass Spectrometry Confirmation: Perform immunoprecipitation with SE14 Antibody followed by mass spectrometry analysis to confirm the identity of the pulled-down protein.

  • Immunofluorescence Correlation: Compare immunofluorescence localization patterns with fluorescently-tagged SE14 protein expression patterns.

  • Cross-Species Reactivity Assessment: Test antibody reactivity against closely related proteins from other plant species with varying degrees of sequence homology to establish specificity boundaries.

  • Multiple Antibody Comparison: If available, compare results with other antibodies targeting different epitopes of the same protein.

  • Concentration Gradient Analysis: Test different antibody dilutions to determine the optimal concentration that maximizes specific signal while minimizing background.

Documentation of these validation steps is crucial for publication and ensures experimental robustness when expanding SE14 Antibody applications beyond its originally tested systems .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.